Thromboprophylaxis in Patients With COVID-19

This publication has 22 references indexed in Scilit:

• Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
  Chest, 2021
• Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
  Thrombosis Research, 2020
• Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
  Thrombosis and Haemostasis, 2020
• Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019
  Chest, 2020
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
  JACC, 2020
• Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19
  Journal of Thrombosis and Haemostasis, 2020
• Characteristics of emergency patients with markedly elevated D-dimer levels
  Scientific Reports, 2020
• Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
  Journal of Thrombosis and Haemostasis, 2020
• RoB 2: a revised tool for assessing risk of bias in randomised trials
  BMJ, 2019
• GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
  BMJ, 2016